Long-term plasma levels of leptin and adiponectin in Rett syndrome

P Blardi1, A de Lalla, T D'Ambrogio

  • 1Center of Clinical Pharmacology, University of Siena, Siena, Italy. blardi@unisi.it

Clinical Endocrinology
|August 20, 2008
PubMed

Insights

In Rett syndrome, plasma leptin levels rise while adiponectin levels fall over two years. These hormones, linked to weight regulation, may influence Rett syndrome

Area of Science:

  • Neuroendocrinology
  • Metabolic disorders
  • Rare genetic diseases

Background:

  • Rett syndrome is a severe neurodevelopmental disorder primarily affecting females.
  • Leptin and adiponectin are key hormones regulating body weight and energy metabolism.
  • Their role in Rett syndrome pathophysiology is not fully understood.

Purpose of the Study:

  • To investigate longitudinal changes in plasma leptin and adiponectin levels in patients with Rett syndrome.
  • To compare these levels with healthy controls over a two-year period.
  • To explore the relationship between leptin and adiponectin in Rett syndrome.

Main Methods:

  • Longitudinal study of 16 female patients with classical Rett syndrome and 16 healthy female controls.
  • Plasma samples collected at baseline, 12, and 24 months.
  • Quantification of leptin and adiponectin using ELISA.

Main Results:

  • Patients showed significantly increased leptin and decreased adiponectin over two years.
  • Leptin and adiponectin levels were significantly higher in patients than controls at all time points.
  • A significant positive correlation between leptin and adiponectin was observed in patients, but not controls.

Conclusions:

  • Altered leptin and adiponectin dynamics in Rett syndrome suggest roles beyond weight regulation.
  • These hormones may be involved in the complex clinical manifestations of Rett syndrome.
  • Further research is warranted to elucidate the specific mechanisms.
Abstract